BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8622970)

  • 1. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.
    Black ME; Newcomb TG; Wilson HM; Loeb LA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3525-9. PubMed ID: 8622970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity.
    Kokoris MS; Black ME
    Protein Sci; 2002 Sep; 11(9):2267-72. PubMed ID: 12192082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing.
    Black ME; Kokoris MS; Sabo P
    Cancer Res; 2001 Apr; 61(7):3022-6. PubMed ID: 11306482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of mutant HSV-1 thymidine kinases for suicide gene therapy.
    Kokoris MS; Sabo P; Black ME
    Anticancer Res; 2000; 20(2A):959-63. PubMed ID: 10810381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2000 Dec; 58(6):1326-32. PubMed ID: 11093770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
    Kokoris MS; Sabo P; Adman ET; Black ME
    Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein.
    Sethi N; Palefsky J
    Hum Gene Ther; 2003 Jan; 14(1):45-57. PubMed ID: 12573058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative mutations of glutamine-125 in herpes simplex virus type 1 thymidine kinase result in a ganciclovir kinase with minimal deoxypyrimidine kinase activities.
    Hinds TA; Compadre C; Hurlburt BK; Drake RR
    Biochemistry; 2000 Apr; 39(14):4105-11. PubMed ID: 10747801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies.
    Mercer KE; Ahn CE; Coke A; Compadre CM; Drake RR
    Protein Eng; 2002 Nov; 15(11):903-11. PubMed ID: 12538910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of important residues within the putative nucleoside binding site of HSV-1 thymidine kinase by random sequence selection: analysis of selected mutants in vitro.
    Black ME; Loeb LA
    Biochemistry; 1993 Nov; 32(43):11618-26. PubMed ID: 8218229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of scopadulciol-related molecules for their stimulatory effect on the cytotoxicity of acyclovir and ganciclovir against Herpes simplex virus type 1 thymidine kinase gene-transfected HeLa cells.
    Hayashi K; Rahman SM; Ohno H; Tanaka T; Toyooka N; Nemoto H; Hayashi T
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):1015-7. PubMed ID: 15305006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA; Docherty JJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A designed equine herpes thymidine kinase (EHV4 TK) variant improves ganciclovir-induced cell-killing.
    McSorley T; Ort S; Monnerjahn C; Konrad M
    Biochem Pharmacol; 2014 Feb; 87(3):435-44. PubMed ID: 24316433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective killing of Leishmania amastigotes expressing a thymidine kinase suicide gene.
    Muyombwe A; Olivier M; Ouellette M; Papadopoulou B
    Exp Parasitol; 1997 Jan; 85(1):35-42. PubMed ID: 9024200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase.
    Balzarini J; Liekens S; Esnouf R; De Clercq E
    Biochemistry; 2002 May; 41(20):6517-24. PubMed ID: 12009916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
    Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M
    Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.